Back

Is the optimal blanking period duration after cryoballoon pulmonary vein isolation impacted by use of antiarrhythmic drugs?

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Treatment of atrial fibrillation and stroke prevention Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Dan Musat

The Valley Hospital, Paramus (United States of America)

6 More presentations in this session

Presentation thumbnail
Incidence and location of residual gaps identified by a high-density grid-style catheter after PVI is confirmed by pacing the ablation lines
Doctor S. Sundaram (Littleton, US)
Abstract Slides Video
Presentation thumbnail
Catheter ablation outscores all other treatment modalities in reducing all-cause mortality and heart failure related morbidity in patients of persistent atrial fibrillation with systolic heart failure
Doctor D. Khanra (CHESTER, GB)
Abstract Slides Video
Presentation thumbnail
Efficacy and safety of a high power short duration ablation-index guided protocol for pulmonary vein isolation using a single catheter
Doctor P. Badertscher (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Shorter interlesion distance is associated with a longer procedure time but not with poorer acute results of pulmonary vein isolation: results from a prospective ablation index registry
Doctor N. Gasimova (Saint Petersburg, RU)
Abstract Slides Video
Presentation thumbnail
Incidence of new-onset atrial fibrillation after cavotricuspid isthmus ablation for isolated typical atrial flutter: a systematic review and meta-analysis
Doctor A. Griffin (Adelaide, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Treatment of atrial fibrillation and stroke prevention

The Event

Event poster

EHRA 2021

23 April - 25 April 2021

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources